Studies On Treating COVID-19 Inflammation And Migraines Also Weigh Efficacy Of Remote Trials
Heartburn Drug Famotidine Tested With COVID Patients, Nestle Keto Supplement For Migraines
Executive Summary
Preliminary data from Cold Springs Harbor Laboratory study suggest famotidine could mitigate inflammatory symptoms of COVID-19 in adults. Research sponsored by Nestle Health Science in Canada also points to remote studies likely to continue after emerging as a pandemic innovation.
You may also be interested in...
Tylenol Leads OTC Acetaminophen Sales Surge After Ibuprofen Scare During Pandemic – IRI
J&J leads sales growth in OTC pain relief and allergy categories in 2020 as its brands benefited from competing products’ problems and COVID-19’s impact of consumer habits. IRI reveals winning brands that kept a focus on maintaining health in 2020.
It’s Been Over 1100 Days Since MCIT, Still No TCET In Sight
AdvaMed’s new online clock documents the time since CMS promised to replace MCIT, a program guaranteeing coverage for FDA-cleared breakthrough devices.
NAM’S Health Care AI Development Code Of Conduct Addresses Gaps In Current Principles
The National Academy of Medicine developed a code of conduct for health care AI development, as well as commitments for code implementation.